semaglutide deadline As new versions of GLP-1 weight-loss pens enter the market, they are raising questions that extend far beyond competition. How should synthetic analogues of these medicines be regulated? And what level of FDA is cracking down on

Among patients receiving concomitant sodiumglucose cotransporter-2 (SGLT2) inhibitors at baseline, no meaningful difference to those patients without concomitant SGLT2 inhibitor use was observed

This includes individuals who have had pancreatitis, medullary thyroid carcinoma, or those with a family history of MTC (medullary thyroid carcinoma) or a family history of multiple endocrine neoplasia (MEN) 2

Give your physician the most complete amount of context by starting a health journal to note down exactly how youre feeling over the duration of your treatment

If you want a tirzepatide-focused walkthrough of that process, this injection guide is a useful reference